Bridgewater Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.3M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $286K | Sell |
|
|||||
|
2024
Q3 | $1.61M | Sell |
|
|||||
|
2024
Q2 | $15.6M | Sell |
|
|||||
|
2024
Q1 | $56.3M | Buy |
|
|||||
|
2023
Q4 | $53.9M | Sell |
|
|||||
|
2023
Q3 | $55.1M | Sell |
|
|||||
|
2023
Q2 | $62M | Sell |
|
|||||
|
2023
Q1 | $64.4M | Buy |
|
|||||
|
2022
Q4 | $29.1M | Sell |
|
|||||
|
2022
Q3 | $47.5M | Sell |
|
|||||
|
2022
Q2 | $61.2M | Buy |
|
|||||
|
2022
Q1 | $7.87M | Buy |
|
|||||
|
2021
Q4 | $2.73M | Sell |
|
|||||
|
2021
Q3 | $2.74M | Sell |
|
|||||
|
2021
Q2 | $4.69M | Buy |
|
|||||
|
2021
Q1 | $4.66M | Buy |
|
|||||
|
2020
Q4 | $858K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $5.46M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $4.03M | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.64M | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $2.41M | Buy |
|